Takuro Kanekura 1, Koichi Kawahara 2 , Int J Infect Dis 2020 Oct;99:1-2.
Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19
To our knowledge, GMA has a good safety profile; serious adverse effects are rarely reported. Its modes of action together with the findings of this case report support our notion that GMA is a relevant therapeutic option for patients with COVID-19 and warrants an immediate clinical trial to evaluate its full therapeutic efficacy in a large cohort of COVID-19 patients.
Contact UsFor more informationContact Us